Karuna Therapeutics, Inc.
KRTXDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771917
Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Karuna Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 289
- +42 vs. Q1 2023
- Shares held
- 37.7M
- −1.00M (−2.6%) vs. Q1 2023
- Total value
- $8.16B
- +$1.14B (+16.2%) vs. Q1 2023
- New holders
- 72
- 92 more added
- Sold out
- 30
- 90 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $269.8K |
| Q4 2023 | 328 | $12.0B |
| Q3 2023 | 257 | $6.46B |
| Q2 2023 | 289 | $8.16B |
| Q1 2023 | 247 | $7.02B |
| Q4 2022 | 248 | $6.81B |
| Q3 2022 | 256 | $7.65B |
| Q2 2022 | 195 | $3.77B |
| Q1 2022 | 178 | $3.73B |
| Q4 2021 | 171 | $3.83B |
| Q3 2021 | 159 | $3.13B |
| Q2 2021 | 160 | $2.93B |
| Q1 2021 | 157 | $3.02B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Karuna Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −4,751−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −2,900−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,558−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −1,862−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,751−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −1,747−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,747−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −1,726−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −1,489−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −1,220−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −173−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Syverson Strege & Co | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |